Global Infectious Disease Diagnostics Testing Market Growth (Status and Outlook) 2023-2029

Global Infectious Disease Diagnostics Testing Market Growth (Status and Outlook) 2023-2029

In hospitals, infectious disease specialists help ensure the timely diagnosis and treatment of acute infections by recommending the appropriate diagnostic tests to identify the source of the infection and by recommending the appropriate antibiotic to treat the infection.

LPI (LP Information)' newest research report, the “Infectious Disease Diagnostics Testing Industry Forecast” looks at past sales and reviews total world Infectious Disease Diagnostics Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Infectious Disease Diagnostics Testing sales for 2023 through 2029. With Infectious Disease Diagnostics Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Diagnostics Testing industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Diagnostics Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease Diagnostics Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Diagnostics Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Diagnostics Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Diagnostics Testing.

The global Infectious Disease Diagnostics Testing market size is projected to grow from US$ 16150 million in 2022 to US$ 20720 million in 2029; it is expected to grow at a CAGR of 3.6% from 2023 to 2029.

Biochemical tests used in the identification of infectious agents include the detection of metabolic or enzymatic products characteristic of a particular infectious agent. Since bacteria ferment carbohydrates in patterns characteristic of their genus and species, the detection of fermentation products is commonly used in bacterial identification. Acids, alcohols and gases are usually detected in these tests when bacteria are grown in selective liquid or solid media.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Diagnostics Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Molecular Diagnostic Test
POC Infectious Disease Diagnostics Test

Segmentation by application
Hospital
Academics Research
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
bioMérieux
Diasorin
Roche Diagnostic
Beckman Coulter
Becton, Dickinson and Company
Bio-Rad Laboratories
Cavidi
Cepheid
Corgenix
Diaxonhit
Eiken Chemical
EMD Millipore
Epitope Diagnostic
EUROIMMUN
Gold Standard Diagnostics
Hologic
Immunetics
InBios International

Please note: The report will take approximately 2 business days to prepare and deliver.